Stryker Corporation SYK

NYSE · Healthcare · Medical - Devices

$310.00

Close on Fri, 20 Nov 2026 · market value $118B

What the price is betting on

In line with its record

At $310, the price assumes revenue grows about 8.3% a year for five years, from $26.3B to about $36.9B by FY2030. That is about the same as what analysts expect for the next two years and about the same as the company's own last three years.

The price assumes8.3%
Analysts, next two years7.3%
Last 3 years9.5%

Revenue growth a year. The price figure comes from a reverse DCF at a 8.3% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than SYK? Check up to 5 of your stocks at once, free, no account.

0$10B$20B$30B$40B$26.3B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$249

Base

$292

Bull

$343

Today $310

  • Bear $249. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $292. Cash flow grows 7% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $343. Cash flow grows 10% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$26.8B$26.8B, on the path
  3. FY2027$29.1B$28.7B, on the path
  4. FY2028$31.5B$30.9B, on the path
  5. FY2029$34.1B$33B, below the path
  6. FY2030$36.9B$35.3B, below the path

Each year's revenue at 8.3% growth from $26.3B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Devices · listed on NYSE

Revenue, FY2025
$25.1B
Growth, 3 years a year
9.5%
Cash margin
17%
Net debt
$12.3B
Shares, 3-year change
0%
Dividend yield
1.1%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.